» Articles » PMID: 35976756

Gynaecological Management of Women with Inherited Bleeding Disorders. A UK Haemophilia Centres Doctors' Organisation Guideline

Overview
Journal Haemophilia
Specialty Hematology
Date 2022 Aug 17
PMID 35976756
Authors
Affiliations
Soon will be listed here.
Abstract

Women with inherited bleeding disorders (IBDs) may present to healthcare professionals in a variety of ways and commonly will be encountered by either haematology or gynaecology services. Heavy menstrual bleeding is very often the first manifestation of an IBD. There is a wide variation in severity of bleeding for women with IBD and diagnosis and subsequent management of their condition requires multidisciplinary specialised care which is tailored to the individual and includes excellent cross-specialty communication between gynaecology and haematology teams. This guideline is intended for both haematologists and gynaecologists who are involved in the diagnosis and management of women with bleeding disorders. It sets out recommendations about how to investigate heavy menstrual bleeding (HMB), the commonest presentation for women with IBD to hospital services, to guide physicians about how to diagnose an IBD and covers the management of women with known IBD and HMB. The second section sets out recommendations for patients known to have IBD and covers management of patients with IBD in the setting of gynaecological surgery and management for all other non-surgical gynaecological situations.

Citing Articles

Clinical Spectrum and Treatment Outcomes of Rare Bleeding Disorders in Female Patients: A Two-Center Experience in North Pakistan.

Usman M, Shahbaz N, Khan M, Tariq H, Mahmood R, Jamshed S Cureus. 2025; 17(1):e77533.

PMID: 39958127 PMC: 11830413. DOI: 10.7759/cureus.77533.


The Menstrual Cycle as a Vital Sign: a comprehensive review.

Vollmar A, Mahalingaiah S, Jukic A F S Rev. 2025; 6(1).

PMID: 39906529 PMC: 11790291. DOI: 10.1016/j.xfnr.2024.100081.


One day at a time: Life with Glanzmann thrombasthenia - Qualitative results from the GT 360 study.

Khair K, Fletcher S, Jenner K, Holland M Haemophilia. 2024; 30(6):1373-1382.

PMID: 39545676 PMC: 11659491. DOI: 10.1111/hae.15126.


Laboratory and Molecular Diagnosis of Factor XI Deficiency.

Davidson S, Gomez K Semin Thromb Hemost. 2024; 51(2):145-154.

PMID: 39496302 PMC: 11906224. DOI: 10.1055/s-0044-1792033.


Clotting Factor Deficiencies as an Underlying Cause of Abnormal Uterine Bleeding in Women of Reproductive Age: A Literature Review.

Livanou M, Matsas A, Valsami S, Papadimitriou D, Kontogiannis A, Christopoulos P Life (Basel). 2023; 13(6).

PMID: 37374104 PMC: 10303428. DOI: 10.3390/life13061321.